SEGMENT INFORMATION

The company consists of 13 businesses which are aggregated into eight reportable segments based on similar economic characteristics, the nature of the products and production processes, end-use markets, channels of distribution and regulatory environment. The company's reportable segments are Agriculture, Electronics & Communications, Industrial Biosciences, Nutrition & Health, Performance Chemicals, Performance Materials, Safety & Protection and Pharmaceuticals. The company includes certain embryonic businesses not included in the reportable segments, such as pre-commercial programs, and nonaligned businesses in Other.

Major products by segment include: Agriculture (corn hybrids and soybean varieties, herbicides, fungicides and insecticides); Electronics & Communications (photopolymers and electronic materials); Industrial Biosciences (enzymes and bio-based materials); Nutrition & Health (cultures, emulsifiers, gums, natural sweeteners and soy-based food ingredients): Performance Chemicals (fluorochemicals, fluoropolymers, specialty and industrial chemicals, and white pigments); Performance Materials (engineering polymers, packaging and industrial polymers, films and elastomers); Safety & Protection (nonwovens, aramids and solid surfaces); and Pharmaceuticals (representing the company's interest in the collaboration relating to Cozaar^®/Hyzaar^® antihypertensive drugs, which is reported as other income). The company operates globally in substantially all of its product lines.

In general, the accounting policies of the segments are the same as those described in Note 1. Exceptions are noted as follows and are shown in the reconciliations below. Segment sales include transfers to another business segment. Products are transferred between segments on a basis intended to reflect, as nearly as practicable, the market value of the products. Segment pre-tax operating income (loss) (PTOI) is defined as income (loss) from continuing operations before income taxes excluding exchange gains (losses), corporate expenses and interest. Segment net assets includes net working capital, net property, plant and equipment and other noncurrent operating assets and liabilities of the segment. Affiliate net assets (pro rata share) excludes borrowing and other long-term liabilities. Depreciation and amortization includes depreciation on research and development facilities and amortization of other intangible assets, excluding write-down of assets. Prior years' data have been reclassified to reflect the current organizational structure.



	Agriculture		Electronics & Communications		Industrial Biosciences			Nutrition & Health		Performance Chemicals		Performance Materials		Safety & Protection		Pharma- ceuticals			Other			Total
2012
Segment sales	$	10,426	$	2,701	$	1,180		$	3,422	$	7,188	$	6,447	$	3,825	$	—		$	5		$	35,194
Less: Transfers	5		17		11			—		247		91		11		—			—			382
Net sales	10,421		2,684		1,169			3,422		6,941		6,356		3,814		—			5			34,812
PTOI	1,594		135		168			299		1,586		1,013		360		62			(385		)	4,832
Depreciation and amortization	337		113		79			288		245		182		197		—			1			1,442
Equity in earnings of affiliates	30		19		1			—		28		42		32		—			(53		)	99
Segment net assets	4,539		1,534		2,571			6,515		3,663		3,537		2,970		(18		)	73			25,384
Affiliate net assets	389		151		53			8		180		567		106		—			14			1,468
Purchases of property, plant and equipment	432		71		80			148		389		186		118		—			7			1,431
2011
Segment sales	$	9,166	$	3,173	$	705		$	2,460	$	7,794	$	6,815	$	3,934	$	—		$	40		$	34,087
Less: Transfers	1		19		7			—		257		109		13		—			—			406
Net sales	9,165		3,154		698			2,460		7,537		6,706		3,921		—			40			33,681
PTOI	1,527		355		(1		)	44		1,923		971		500		289			(263		)	5,345
Depreciation and amortization	295		99		47			207		252		199		172		—			2			1,273
Equity in earnings of affiliates	58		19		(3		)	—		43		74		47		—			(47		)	191
Segment net assets	4,754		1,867		2,542			6,225		3,536		3,468		3,055		35			69			25,551
Affiliate net assets	330		197		52			1		201		445		111		—			34			1,371
Purchases of property, plant and equipment	420		198		61			115		326		197		208		—			5			1,530
2010
Segment sales	$	7,845	$	2,764	$	—		$	1,240	$	6,322	$	6,287	$	3,364	$	—		$	194		$	28,016
Less: Transfers	1		17		—			—		216		69		12		—			1			316
Net sales	7,844		2,747		—			1,240		6,106		6,218		3,352		—			193			27,700
PTOI	1,293		445		—			62		1,081		994		454		489			(205		)	4,613
Depreciation and amortization	265		94		—			109		266		205		151		—			4			1,094
Equity in earnings of affiliates	59		26		—			—		24		77		37		—			(45		)	178
Segment net assets	4,903		1,639		—			950		3,310		3,512		2,955		40			233			17,542
Affiliate net assets	289		195		—			2		184		485		103		—			90			1,348
Purchases of property, plant and equipment	360		260		—			39		225		190		215		—			11			1,300

Reconciliation to Consolidated Financial Statements



PTOI to income from continuing operations before income taxes	2012			2011			2010
Total segment PTOI	$	4,832		$	5,345		$	4,613
Net exchange losses, including affiliates	(215		)	(146		)	(11		)
Corporate expenses and net interest	(1,502		)	(1,418		)	(1,342		)
Income from continuing operations before income taxes	$	3,115		$	3,781		$	3,260



Segment net assets to total assets at December 31,	2012		2011		2010
Total segment net assets	$	25,384	$	25,551	$	17,542
Corporate assets¹	10,625		10,085		11,312
Liabilities included in segment net assets	10,671		9,882		8,524
Assets related to discontinued operations²	3,056		2,974		3,032
Total assets	$	49,736	$	48,492	$	40,410


^1.	Pension assets are included in corporate assets.


^2.	See Note 1 for additional information on the presentation of the Performance Coatings business which met the criteria for discontinued operations during 2012.



Other items¹	Segment Totals		Adjustments			Consolidated Totals
2012
Depreciation and amortization	$	1,442	$	271		$	1,713
Equity in earnings of affiliates	99		3			102
Affiliate net assets	1,468		(305		)	1,163
Purchases of property, plant and equipment	1,431		362			1,793
2011
Depreciation and amortization	$	1,273	$	287		$	1,560
Equity in earnings of affiliates	191		1			192
Affiliate net assets	1,371		(254		)	1,117
Purchases of property, plant and equipment	1,530		313			1,843
2010
Depreciation and amortization	$	1,094	$	286		$	1,380
Equity in earnings of affiliates	178		(1		)	177
Affiliate net assets	1,348		(307		)	1,041
Purchases of property, plant and equipment	1,300		208			1,508


^1.	See Note 1 for additional information on the presentation of the Performance Coatings business which met the criteria for discontinued operations during 2012.

Additional Segment Details

2012 included the following pre-tax benefits (charges):



Agriculture^1,2,3	$	(469	)
Electronics & Communications^3,4,5	(37		)
Industrial Biosciences³	(3		)
Nutrition & Health³	(49		)
Performance Chemicals^3,5	(36		)
Performance Materials^3,5	(104		)
Safety & Protection³	(58		)
Other^3,6	(126		)
	$	(882	)


^1.	Included a $(575) charge recorded in cost of goods sold and other operating charges associated with the company's process to fairly resolve claims related to the use of Imprelis^®. See Note 16 for additional information.


^2.	Included a $117 gain recorded in other income, net associated with the sale of a business.

^3.

Included a $(134) restructuring charge recorded in employee separation/asset related charges, net primarily as a result of the company's plan to eliminate corporate costs previously allocated to Performance Coatings and cost-cutting actions to improve competitiveness, partially offset by a reversal of prior year restructuring accruals. Charges by segment were: Agriculture - $(11); Electronics & Communications - $(9); Industrial Biosciences - $(3); Nutrition & Health - $(49); Performance Chemicals - $(3); Performance Materials - $(12); Safety & Protection - $(58); and Other - $11. See Note 3 for additional information.


^4.	Included a $122 gain recorded in other income, net associated with the sale of an equity method investment.


^5.	Included a $(275) impairment charge recorded in employee separation/asset related charges, net related to asset groupings, which impacted the segments as follows: Electronics & Communications - $(150); Performance Chemicals - $(33); and Performance Materials - $(92). See Note 3 for additional information.


^6.	Included a $(137) charge in cost of goods sold and other operating charges primarily related to the company's settlement of litigation with INVISTA.

2011 included the following pre-tax benefits (charges):



Agriculture^1,2	$	(225	)
Industrial Biosciences^3,4	(79		)
Nutrition & Health^3,4	(126		)
Performance Materials^4,5	47
Other⁴	(28		)
	$	(411	)


^1.	Included a $(50) charge recorded in research and development expense in connection with a milestone payment associated with a Pioneer licensing agreement. Since this milestone was reached before regulatory approval was secured by Pioneer, it was charged to research and development expense.


^2.	Included a $(175) charge recorded in cost of goods sold and other operating charges associated with the company's process to fairly resolve claims associated with the use of Imprelis^®. See Note 16 for additional information.


^3.	Included a $(182) charge for transaction related costs and the fair value step-up of inventories that were acquired as part of the Danisco transaction, which impacted the segments as follows: Industrial Biosciences - $(70) and Nutrition & Health - $(112).


^4.	Included a $(53) restructuring charge primarily related to severance and related benefit costs associated with the Danisco acquisition impacting the segments as follows: Industrial Biosciences - $(9); Nutrition & Health - $(14); Performance Materials - $(2); and Other - $(28). See Note 3 for additional information.


^5.	Included a $49 benefit recorded in other income, net associated with the sale of a business.

2010 included the following pre-tax benefits (charges):



Agriculture¹	$	(50	)
Electronics & Communications²	8
Performance Chemicals²	10
Performance Materials²	16
Safety & Protection²	5
Other²	1
	$	(10	)


^1.	Included a $(50) charge in research and development expense for an upfront payment related to a Pioneer licensing agreement. Since this payment was made before regulatory approval was secured by Pioneer, it was charged to research and development expense.


^2.	Included a $40 reduction in estimated restructuring costs related to restructuring programs impacting the segments as follows: Electronics & Communications – $8; Performance Chemicals – $10; Performance Materials – $16; Safety & Protection – $5; and Other – $1.